TrustCore Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

TrustCore Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$33.6K	Hold	211	–	–	﹤0.01%	523
2022 Q3	$28K	Sell	211 -136	-39%	-$20.7K	﹤0.01%	555
2022 Q2	$54K	Hold	347	–	–	0.01%	436
2022 Q1	$54K	Buy	347 +112	+48%	+$16.3K	﹤0.01%	454
2021 Q4	$30K	Sell	235 -112	-32%	-$14.7K	﹤0.01%	540
2021 Q3	$45K	Hold	347	–	–	﹤0.01%	495
2021 Q2	$62K	Buy	347 +157	+83%	+$27.2K	0.01%	420
2021 Q1	$31K	Hold	190	–	–	﹤0.01%	520
2020 Q4	$31K	Hold	190	–	–	﹤0.01%	488
2020 Q3	$27K	Hold	190	–	–	﹤0.01%	466
2020 Q2	$21K	Sell	190 -100	-34%	-$11.1K	﹤0.01%	514
2020 Q1	$29K	Hold	290	–	–	0.01%	429
2019 Q4	$43K	Buy	290 +100	+53%	+$13.6K	0.01%	396
2019 Q3	$24K	Hold	190	–	–	0.01%	478
2019 Q2	$27K	Hold	190	–	–	0.01%	456
2019 Q1	$27K	Hold	190	–	–	0.01%	389
2018 Q4	$24K	Hold	190	–	–	0.01%	205
2018 Q3	$32K	Sell	190 -15	-7%	-$2.58K	0.01%	370
2018 Q2	$35K	Buy	205 +15	+8%	+$2.45K	0.01%	349
2018 Q1	$29K	Hold	190	–	–	0.01%	351
2017 Q4	$26K	Buy	+190	New	+$26.4K	0.01%	355

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

TrustCore Financial Services's JAZZ Position: Q4 2022 in Review

TrustCore Financial Services held its Jazz Pharmaceuticals (JAZZ) position steady in Q4 2022 at 211 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #523.

TrustCore Financial Services first reported a position in JAZZ in Q4 2017 and has held it in 21 quarters since. The position peaked at $62K in Q2 2021. 486 funds tracked by Wall St. Rank hold JAZZ as of Q4 2022.

TrustCore Financial Services held 211 shares of Jazz Pharmaceuticals worth $33.6K as of Q4 2022.
TrustCore Financial Services left its Jazz Pharmaceuticals share count unchanged in Q4 2022.
Jazz Pharmaceuticals made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #523 holding.
TrustCore Financial Services first reported a position in Jazz Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
TrustCore Financial Services's Jazz Pharmaceuticals position peaked at $62K in Q2 2021.
486 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.